News

Stocktwits on MSN52m
Sarepta Pauses Shipments Of DMD Drug Elevidys Amid FDA Label Review, Stock Tumbles After-Hours
Sarepta Therapeutics shares closed over 5.3% lower on Monday, hitting more than a nine-year low, and fell another 8.5% in ...
Stockhead on MSN30m
Health Check: Bug buster Genetic Signatures’ US expansion is a jumbo-sized task
Tummy bug testing outfit Genetic Signatures is honing its operations after finding its company-making US expansion was harder than expected. ... Read More The post Health Check: Bug buster Genetic ...